Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amgen

298.81
+3.001.01%
Post-market: 298.810.00000.00%19:54 EDT
Volume:1.96M
Turnover:582.45M
Market Cap:160.87B
PE:24.43
High:299.37
Open:295.24
Low:293.14
Close:295.81
52wk High:335.88
52wk Low:253.30
Shares:538.36M
Float Shares:536.99M
Volume Ratio:0.92
T/O Rate:0.36%
Dividend:9.26
Dividend Rate:3.10%
EPS(TTM):12.23
EPS(LYR):7.62
ROE:99.14%
ROA:7.51%
PB:21.66
PE(LYR):39.23

Loading ...

Drug Stock Rally Helps Push Dow and S&P 500 to Records -- WSJ

Dow Jones
·
Oct 02

US Equity Indexes Mixed Amid Healthcare Gains While Treasury Yields Drop as Partial Shutdown Begins

MT Newswires Live
·
Oct 02

Biocon Agrees to Settlement With Amgen to Market Osteoporosis Treatments

Dow Jones
·
Oct 01

Immatics NV Appoints Venkat Ramanan as New Chief Financial Officer, Succeeding Arnd Christ

Reuters
·
Oct 01

Biocon Biologics, Amgen Settle Patent Dispute, Clearing US Launch of Denosumab Biosimilars

MT Newswires Live
·
Oct 01

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2025-09-30

Reuters
·
Oct 01

Pfizer not subject to pharma tariffs during 3 year grace period, CEO says

Reuters
·
Oct 01

Corrected-Trump on Pfizer: All Medications Introduced by Pfizer Into U.S. Market Will Be Sold at Mfn Prices (Corrects to Show Trump Was Referring to New Drugs Introduced by Pfizer, Rather Than All Pfizer Drugs)

THOMSON REUTERS
·
Oct 01

Trump: Pfizer Will Offer All of Their Prescription Medications to Medicaid at Mfn Prices

THOMSON REUTERS
·
Sep 30

Trump on Drug Prices: Other Companies Will Be Coming in Over the Next Week

THOMSON REUTERS
·
Sep 30

Trump on Drug Prices: IF They Don't Lower Prices, We'LL Put a Tariff on Them at the Equivalent Amount

THOMSON REUTERS
·
Sep 30

U.S. Commerce Chief on 232 Investigations: While We Negotiate, We Are Going to Let It Play Out

THOMSON REUTERS
·
Sep 30

U.S. FDA Chief on Drugmakers: IF Build in U.S., Will Also Move to Front of Line

THOMSON REUTERS
·
Sep 30

U.S. FDA Chief on Drugmakers: IF You Equalize Your Price, Applications Go to Front of Line

THOMSON REUTERS
·
Sep 30

Trump Other Drugmakers Will Commit in Coming Weeks

THOMSON REUTERS
·
Sep 30

Trump: Medicines Will Be Available for Direct Purchase on U.S. Gov't Website

THOMSON REUTERS
·
Sep 30

Trump: Will Be at the Most Favored Nation Prices

THOMSON REUTERS
·
Sep 30

Trump: Will Help Bring Medicaid Costs Down

THOMSON REUTERS
·
Sep 30

Dow 30 Component Amgen Rises 2.4% in Early Trading

Deep News
·
Sep 30

Crystalys Therapeutics launches with $205 million funding round for trials of gout drug

Reuters
·
Sep 30